<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR184">
 <label>184.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Boyerinas</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Jochems</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Fantini</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Heery</surname>
    <given-names>C. R.</given-names>
   </name>
   <name>
    <surname>Gulley</surname>
    <given-names>J. L.</given-names>
   </name>
   <name>
    <surname>Tsang</surname>
    <given-names>K. Y.</given-names>
   </name>
   <name>
    <surname>Schlom</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells</article-title>
  <source>Cancer Immunology Research</source>
  <year>2015</year>
  <volume>3</volume>
  <issue>10</issue>
  <fpage>1148</fpage>
  <lpage>1157</lpage>
  <pub-id pub-id-type="doi">10.1158/2326-6066.CIR-15-0059</pub-id>
  <?supplied-pmid 26014098?>
  <pub-id pub-id-type="pmid">26014098</pub-id>
 </element-citation>
</ref>
